HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

IgD plasma cell leukemia and uterine malignant mixed Müllerian tumor.

Abstract
The case of a 74-year-old female with an IgD kappa plasma cell leukemia is presented. In contrast to the majority of the cases in the literature, this patient responded rather well to melphalan and prednisolone and survived for 20 months after starting treatment. Another remarkable feature was the simultaneous occurrence of a double uterine neoplasm, a malignant mixed Müllerian tumor of the homologous variety (also called carcinosarcoma).
AuthorsZ N Berneman, R Mathijs, J M Bultinck, C Mahler
JournalActa haematologica (Acta Haematol) Vol. 72 Issue 1 Pg. 52-6 ( 1984) ISSN: 0001-5792 [Print] Switzerland
PMID6433634 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Gentamicins
  • Immunoglobulin D
  • Immunoglobulin kappa-Chains
  • Allopurinol
  • Ampicillin
  • Prednisolone
  • Melphalan
Topics
  • Adnexa Uteri (surgery)
  • Aged
  • Allopurinol (therapeutic use)
  • Ampicillin (therapeutic use)
  • Carcinosarcoma (complications)
  • Female
  • Gentamicins (therapeutic use)
  • Humans
  • Hysterectomy
  • Immunoglobulin D (metabolism)
  • Immunoglobulin kappa-Chains (metabolism)
  • Leukemia, Plasma Cell (complications, drug therapy)
  • Melphalan (therapeutic use)
  • Pneumonia (drug therapy, etiology)
  • Prednisolone (therapeutic use)
  • Uterine Neoplasms (complications, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: